| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Destiny Pharma plc (LSE: DEST)
DEST Technical Analysis
5
| As on 12th Aug 2024 DEST STOCK Price closed @ 3.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 47.80 & Strong Sell for SHORT-TERM with Stoploss of 32.90 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DESTSTOCK Price
| Open | 4.00 | Change | Price | % |
| High | 5.00 | 1 Day | -0.50 | -14.29 |
| Low | 2.55 | 1 Week | 0.48 | 19.05 |
| Close | 3.00 | 1 Month | -5.75 | -65.71 |
| Volume | 4095282 | 1 Year | -32.25 | -91.49 |
| 52 Week High 82.00 | 52 Week Low 2.25 | ||||
LSE UK Most Active Stocks
| NTOG | 0.02 | 0.00% |
| CPX | 0.14 | 7.69% |
| MSMN | 0.04 | 0.00% |
| VELA | 0.01 | % |
| TRP | 0.03 | % |
| SCGL | 0.27 | 92.86% |
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
| DMTR | 0.03 | 0.00% |
| VAST | 0.08 | 14.29% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| DEST Daily Charts |
DEST Intraday Charts |
Whats New @ Bazaartrend |
DEST Free Analysis |
|
|
DEST Important Levels Intraday
| RESISTANCE | 7.72 |
| RESISTANCE | 6.21 |
| RESISTANCE | 5.27 |
| RESISTANCE | 4.34 |
| SUPPORT | 1.66 |
| SUPPORT | 0.73 |
| SUPPORT | -0.21 |
| SUPPORT | -1.72 |
DEST Forecast November 2024
| 4th UP Forecast | 20.34 |
| 3rd UP Forecast | 14.78 |
| 2nd UP Forecast | 11.34 |
| 1st UP Forecast | 7.91 |
| 1st DOWN Forecast | -1.91 |
| 2nd DOWN Forecast | -5.34 |
| 3rd DOWN Forecast | -8.78 |
| 4th DOWN Forecast | -14.34 |
DEST Weekly Forecast
| 4th UP Forecast | 36.36 |
| 3rd UP Forecast | 25.66 |
| 2nd UP Forecast | 19.05 |
| 1st UP Forecast | 12.43 |
| 1st DOWN Forecast | -6.43 |
| 2nd DOWN Forecast | -13.05 |
| 3rd DOWN Forecast | -19.66 |
| 4th DOWN Forecast | -30.36 |
DEST Forecast2024
| 4th UP Forecast | 161.01 |
| 3rd UP Forecast | 110.34 |
| 2nd UP Forecast | 79.01 |
| 1st UP Forecast | 47.69 |
| 1st DOWN Forecast | -41.69 |
| 2nd DOWN Forecast | -73.01 |
| 3rd DOWN Forecast | -104.34 |
| 4th DOWN Forecast | -155.01 |
Destiny Pharma plc ( LSE UK Symbol : DEST )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DEST Business Profile
Destiny Pharma plc, a biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of infectious diseases in the United Kingdom. The company is involved in developing NTCD-M3 that is in phase III clinical trial for the prevention of recurrent Clostridioides diffcile infections; XF-73 Nasal that is in Phase II clinical trial for the prevention of post-surgical staphylococcal infection; and XF-73 Dermal, which is in Phase I clinical trial for the treatment of skin infections of antibiotic resistant bacteria. It also develops SPOR-COV, biotherapeutic product for the prevention of COVID-19 and other viral respiratory infections; and XF Drugs Biofilm for the treatment of of antibiotic resistant biofilm and bacterial aggregate associated infections. In addition, the company is involved in the development of XF Drugs for the treatment of respiratory, oral mucosa, and ocular infection diseases. Destiny Pharma plc has collaboration agreement with China Medical System Holdings Limited; research collaboration with the University of Southampton for targeting infections in diabetic foot ulcers and cystic fibrosis; research collaboration with the University of Sheffield; research collaboration with Aston University to investigate novel compounds from its XF-drug platform; collaboration with Cardiff University and Tianjin Medical University; and Collaboration with SporeGen Limited to co-develop treatment for COVID-19. The company was incorporated in 1996 and is based in Brighton, the United Kingdom. Address: Sussex Innovation Centre, Brighton, United Kingdom, BN1 9SB
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service